Ambrose Alli University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01152931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Dean, Faculty of Natural Sciences Ambrose Alli University Ekpoma | Department of Pharmacology and Therapeutics, College of Medicine, Ambrose Alli University, Ekpoma

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 8